Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

33.92
-0.3619-1.06%
Post-market: 33.950.0327+0.10%16:10 EDT
Volume:6K
Turnover:198.03K
Market Cap:32.22M
PE:- -
High:33.97
Open:33.93
Low:33.84
Close:34.28
52wk High:36.72
52wk Low:25.59
Shares:950.00K
Float Shares:950.00K
Volume Ratio:0.88
T/O Rate:0.61%
Dividend:0.16
Dividend Rate:0.47%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Yesterday

Mayo Clinic and Thermo Fisher Scientific Launch Precure, Llc to Identify Signs of Disease Before Symptoms Appear

THOMSON REUTERS
·
Yesterday

Abbott’s Volt Pulsed Field Ablation System used for first time in Canada

TIPRANKS
·
Yesterday

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Yesterday

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
Yesterday

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
Yesterday

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Dow Jones Top Company Headlines at 9 PM ET: OpenAI Buys Startup Developing Smartphone Camera | Abbott ...

Dow Jones
·
Yesterday

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Yesterday

Eli Lilly Stock (LLY) Has 45% Upside, Says Citigroup

TIPRANKS
·
Yesterday

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
Yesterday

Eli Lilly Exec Says Co NOW Has More than 30% Share in New Starts Within Oral Obesity Treatment Market -Morgan Stanley Conf

THOMSON REUTERS
·
Yesterday

Eli Lilly and Co Stock (LLY) Moved Up by 3.01% on Sep 14: Drivers Behind the Movement

TradingKey
·
Yesterday

Abbott confirms agreement with DOJ to resolve 2022 formula recall claims

TIPRANKS
·
Yesterday

UnitedHealth Earnings Growth Outlook Unlikely to Change, UBS Says

MT Newswires Live
·
Sep 14

Abbott Agrees to Pay $385 Million to Settle DOJ Claims over 2022 Infant Formula Recall

Reuters
·
Sep 14

Abbott: no Unopened, Distributed Abbott Infant Formulas Have Ever Tested Positive for Cronobacter Sakazakii

THOMSON REUTERS
·
Sep 14